↓ Skip to main content

Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

Overview of attention for article published in Cardiovascular Diabetology, November 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
182 Dimensions

Readers on

mendeley
138 Mendeley